Skip to main content
. 2018 Jan 13;110(7):734–742. doi: 10.1093/jnci/djx260

Table 1.

Characteristics of NSCLC cases, by sex and smoking status (n = 813)

Characteristic Male, never smoker Male, ever smoker Female, never smoker Female, ever smoker
No. (%) No. (%) No. (%) No. (%) P*, males P*, females
Total 45 (100.0) 318 (100.0) 162 (100.0) 288 (100.0)
Age, y .006 .05
 <55 12 (28.6) 31 (10.0) 29 (19.0) 47 (16.7)
 55–64 8 (19.0) 85 (27.5) 38 (24.8) 70 (24.9)
 65–74 12 (28.6) 119 (38.5) 46 (30.1) 116 (41.3)
 75+ 10 (23.8) 74 (24.0) 40 (26.1) 48 (17.1)
Ethnicity .22 .005
 Hispanic 0 (0.0) 10 (3.3) 12 (7.9) 6 (2.2)
 Non-Hispanic 44 (100.0) 290 (96.7) 140 (92.1) 268 (97.8)
 Unknown 1 18 10 14
Race <.001 <.001
 White 37 (82.2) 280 (88.1) 119 (73.5) 267 (92.7)
 Black 0 (0.0) 15 (4.7) 8 (4.9) 11 (3.8)
 Asian 8 (17.8) 9 (2.8) 26 (16.0) 3 (1.0)
 Other 0 (0.0) 14 (4.4) 9 (5.6) 7 (2.4)
Family history of lung cancer .17 .38
 Yes 8 (17.8) 84 (27.4) 38 (24.1) 79 (27.9)
 No 37 (82.2) 223 (72.6) 120 (75.9) 204 (72.1)
 Unknown 0 11 4 5
Histology <.001 <.001
 Adenocarcinoma 35 (77.8) 134 (42.3) 135 (83.9) 161 (56.1)
 Large cell 1 (2.2) 22 (6.9) 1 (0.6) 28 (9.8)
 Other NSCLC 0 (0.0) 30 (9.5) 7 (4.3) 12 (4.2)
 Squamous cell carcinoma 3 (6.7) 122 (38.5) 3 (1.9) 72 (25.1)
 Bronchioloalveolar carcinoma 6 (13.3) 9 (2.8) 15 (9.3) 14 (4.9)
 Unknown 0 1 1 1
Stage .76 .69
 IA 15 (34.9) 91 (28.9) 63 (39.4) 120 (42.0)
 IB 14 (32.6) 100 (31.7) 51 (31.9) 84 (29.4)
 IIA 4 (9.3) 22 (7.0) 7 (4.4) 21 (7.3)
 IIB 3 (7.0) 41 (13.0) 19 (11.9) 27 (9.4)
 IIIA 6 (14.0) 44 (14.0) 12 (7.5) 24 (8.4)
 IIIB 1 (2.3) 17 (5.4) 8 (5.0) 10 (3.5)
 Unknown 2 3 2 2
*

Ever vs never smokers, chi-square test (two-sided). NSCLC = non–small cell lung cancer.